Overall BNTC gets a fundamental rating of 3 out of 10. We evaluated BNTC against 525 industry peers in the Biotechnology industry. While BNTC has a great health rating, there are worries on its profitability. BNTC has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year BNTC has reported negative net income.
In the past year BNTC has reported a negative cash flow from operations.
BNTC had negative earnings in each of the past 5 years.
In the past 5 years BNTC always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -39.75%, BNTC is in line with its industry, outperforming 59.62% of the companies in the same industry.
Looking at the Return On Equity, with a value of -42.86%, BNTC is in the better half of the industry, outperforming 70.10% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-39.75%
ROE	-42.86%
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

BNTC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

BNTC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 30.97 indicates that BNTC is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 30.97, BNTC belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
BNTC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	30.97

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 14.80 indicates that BNTC has no problem at all paying its short term obligations.
BNTC has a better Current ratio (14.80) than 91.62% of its industry peers.
BNTC has a Quick Ratio of 14.80. This indicates that BNTC is financially healthy and has no problem in meeting its short term obligations.
BNTC has a better Quick ratio (14.80) than 91.62% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	14.8
Quick Ratio	14.8

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

BNTC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 80.10%, which is quite impressive.

EPS 1Y (TTM)80.1%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%54.17%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 10.96% on average over the next years. This is quite good.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y31.58%

EPS Next 2Y9.85%

EPS Next 3Y10.96%

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BNTC. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BNTC. No positive earnings are expected for the next year.